BOUNDLESS BIO, INC.

BOLD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $206.4M

Liabilities Breakdown FY2024

Total Liabilities: $55.8M